Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transplant candidates may wait longer for available kidneys

09.09.2004


Researchers from the University of Chicago and Stanford University found that one of the new programs to increase the number of kidneys available for transplantation has disadvantages for candidates with blood type O who are waiting for an organ from a deceased donor. The researchers’ findings appear in the Sept. 15, 2004, issue of Transplantation.



Through a process called list-paired exchange, a person waiting for a kidney transplant gets a higher priority on the wait list for an organ from a deceased donor when a relative makes a living donation to another waiting recipient. The living donor is not able to donate to his or her relative, usually because of blood type incompatibilities, so the willing donor gives his or her kidney to an unknown person on the wait list.

The researchers argue that list-paired exchanges are unethical because they harm an already vulnerable population. The majority of candidates waiting for kidneys have blood type O. They have the longest wait times. Where list-paired exchanges are permitted, the researchers show, wait-list candidates of blood type O are forced to wait even longer for an available deceased donor kidney.


According to the Organ Procurement and Transplantation Network, more than 30,000 people with blood type O in the United States are on the kidney wait list as of July 2004. That’s the largest number of candidates compared to the other blood types (A, B and AB). Individuals of all blood types can receive an organ of blood type O, but those with blood type O can only receive a donation from another individual of blood type O.

"Those who are already worst off – have the longest waiting times – are being asked to wait even longer in order that overall more people are getting organs," said corresponding author Lainie Ross, M.D., Ph.D., associate professor of pediatrics and assistant director of the MacLean Center for Clinical Medical Ethics at the University of Chicago.

"The positive side of list-paired exchanges is that we are going to get more organs into the system, and anything to increase the supply is great," Ross said. "But is it OK to increase the supply of organs if it harms a particular group of people? Justice requires that any new policies that are going to improve the well-being of the community also must benefit those who are worst off."

The United Network of Sharing (UNOS) Region 1, which includes Connecticut, Maine, Massachusetts, New Hampshire and Rhode Island, approved list-paired exchanges in February 2001.

Ross and her colleague noted a 2003 report from Region 1. In that report, all of the eight paired recipients had blood type O, but only one donor did. This means that seven individuals in Region 1 received a deceased donor kidney of blood type O ahead of those on the wait list who did not have an available living donor. The researchers said the data confirm their concern that individuals with blood type O on the wait list will be made worst off by a list-paired exchange program that permits people with incompatible blood types to participate.

In 2002, nearly 2,000 blood type O candidates died while waiting for a kidney from a deceased donor. The researchers calculated that if list-paired exchanges were adopted nationally, it could result in an average increased wait time of seven days for blood type O candidates. This translates into an additional 15 deaths per year. Since kidneys are distributed regionally, it could result in even longer wait times in some areas, the researchers note.

Ross and her colleague do not want to prohibit all list-paired exchanges. They propose limiting list-paired exchanges to pairs who are blood type compatible. They propose prohibiting only those list-paired exchanges that are blood type incompatible when the intended recipient has blood type O. "We need restrictions for list-paired exchanges to make them a moral option," Ross said.

The other author of the study is Stefanos Zenios, Ph.D., associate professor of operations, information and technology at Stanford University’s graduate school of business.

Katie O’Boyle | EurekAlert!
Further information:
http://www.uchospitals.edu

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>